Tech Company Financing Transactions
Reyedar Funding Round
On 7/5/2023, Reyedar landed $3.3 million in funding from Cottonwood Technology Group, Blue Sparrows MedTech Fund and NV NOM.
Transaction Overview
Company Name
Announced On
7/5/2023
Transaction Type
Venture Equity
Amount
$3,260,000
Round
Undisclosed
Investors
Proceeds Purpose
The company will use the funds to commercialise its degenerative disease screening technology.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
L.J. Zielstraweg 2
Groningen, 9713 GX
NL
Groningen, 9713 GX
NL
Phone
Undisclosed
Website
Email Address
Overview
Visual impairments and neurodegenerative disorders such as Glaucoma, Parkinson's Disease, and Multiple Sclerosis, severely impact the quality-of-life of hundreds of millions of people around the world. The accurate detection of early symptoms is critical for a correct treatment but is often not possible. The current screening tests are either invasive, time-consuming or unreliable in clinical populations such as young children or elderly who cannot perform complex, tiring assessments. This causes two main problems: enormous healthcare expenditure for misdiagnosed disorders and severe deteriorations in patients that are not diagnosed in time.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alessandro Grillini
Browse more venture capital transactions:
Prev: 7/5/2023: Hardt Hyperloop venture capital transaction
Next: 7/5/2023: Kinnu venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs